Top hedge fund manager David Neuhauser says the world is in a “boomer renaissance” and investors ought to be betting big on certain sectors that play the theme. The world is aging rapidly, and sectors equivalent to tourism, health care and biotech will profit from that, in response to Neuhauser, who’s founder and chief investment officer of Livermore Partners. Investors should give attention to areas which are “tailored to wealthy boomers” who need to spend on their lifestyles and on improving their health and well-being, he said, adding that examples include weight reduction drugs and traveling and cruises. “They’re the one demographic which owns probably the most assets (homes, stocks, bonds, etc) with low fixed rate mortgages,” Neuhauser said. “A whole lot of those individuals even have money, they usually have money in the cash market accounts, so that they have a good income stream as well and that helps support their lifestyle,” he told CNBC’s ” Street Signs Asia ” last week. Big Pharma particularly has “a lot of money resulting from these aging boomers,” Neuhauser said. He said large pharmaceutical firms may now acquire biotech firms if solid initial results are produced, as a substitute of waiting for the completion of late-stage trials. This, he said, could end in more acquisitions. He told CNBC Pro, “I feel the world is on this boomer renaissance now and there are some stocks which are seeing great moves.” He added that the stocks “will not be mega tech which shows you other areas tied to the wealth [effect] are helping broadening out gains.” Below are the stocks he named and the buy rankings and average upside given by analysts covering them, in response to FactSet.